PLYMOUTH, Minn., May 10, 2010 (GLOBE NEWSWIRE) -- ev3 Inc. (Nasdaq:EVVV) today announced that Robert Palmisano, president and chief executive officer, is scheduled to present at Baird's 2010 Growth Stock Conference at 8:55 a.m. Central Time on Wednesday, May 19, 2010, at the Four Seasons Hotel located at 120 East Delaware Place, Chicago, IL.
To access the webcast, go to the investor relations section of the ev3 Web site at http://ir.ev3.net and click on the Webcast icon. The Webcast will be available for replay approximately one hour after the presentation is complete.
About ev3 Inc.
Since its founding in 2000, ev3 has been dedicated to developing innovative and breakthrough technologies for the endovascular treatment of peripheral vascular and neurovascular diseases. The company offers a comprehensive portfolio of treatment options, including the primary interventional technologies used today -- plaque excision systems, peripheral angioplasty balloons, stents, embolic protection devices, liquid embolics, embolization coils, flow diversion, thrombectomy catheters and occlusion balloons. More information about the company and its products can be found at http://www.ev3.net.
ev3 and the ev3 logo are trademarks of ev3 Inc., registered in the U.S. and other countries.
CONTACT: ev3 Inc. INVESTORS and MEDIA Julie Tracy, Sr. Vice President, Chief Communications Officer (949) 680-1375 jtracy@ev3.net
